KalVista Appoints Jeb Ledell as Chief Operating Officer

KalVista Pharmaceuticals announced that Jeb Ledell has joined the Company as Chief Operating Officer (COO).

Ben Palleiko, Chief Executive Officer of KalVista, said: “I am pleased to welcome Jeb to KalVista at this key time in our evolution. His extensive experience in leading teams and driving efficiency within companies like ours makes him a valued addition to the team as we continue to evolve into a commercial entity. I am confident that his proven skills will help us to achieve our goal of delivering sebetralstat to help transform the lives of people living with hereditary angioedema.”

Jeb Ledell, said: “I am excited to join the talented team at KalVista as the Company prepares to launch sebetralstat on a global scale. I am eager to contribute my insights and experience to drive forward the Company’s mission of delivering a transformative new therapy for those impacted by hereditary angioedema.”

(Source: KalVista)